US-based medical device company MicroAire Surgical Instruments announced on Monday that it has acquired NEOSYAD, a French company that developed a breakthrough technology for adipose tissue engineering.
NEOSYAD has received EU MDR approval for its AdiMate device and Adipure single-use kit. AdiMate is designed to optimise operating times by integrating the infiltration, liposuction and adipose tissue preparation (lipofilling) functions due to its patented 'all-in-one' concept and integrated proprietary software.
The protocol integrated in the machine enables tissue purification in less than 10 minutes in a completely automatic way, while guaranteeing unmatched adipose tissue quality and viability.
Jerome Barrillon, MicroAire president, said: "We are thrilled to welcome the NEOSYAD team into the MicroAire family. Their expertise, innovative products and dedication to advancing adipose tissue technologies perfectly align with our mission to enable better patient outcomes and support plastic surgeons worldwide."
NanoVibronix completes pilot phase of UroShield study at University of Michigan
Hologic acquires Gynesonics for USD350m
Inogen secures FDA clearance for SIMEOX 200 Airway Clearance Device
Microtech commences human clinical trial of microsensor platform for heart failure
Defense Diagnostics launches DEFENT ONE All-In-One Fentanyl Detection Device in US
HeartBeam secures FDA clearance for innovative at-home heart monitoring device
Eli Lilly to expand Wisconsin facility
GC Biopharma and Novel Pharma report first patient dosed in multinational trial of GC1130A
Abbott launches first patient procedures with investigational TAVI system
SHL Medical to establish tooling and automation sub-group
Epigenic Therapeutics receives New Zealand approval for EPI-003 clinical trial
GRAIL reports first patient tested with blood-based assay in TROPION-Lung12 Phase 3 study